tirzepatide patient information for Medical Weight Loss Tirzepatide for Medical Weight Loss

I wish the weight loss meds could be more affordable Thank you Only been on this a month so far

FDA approves Novo Nordisks oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults owenhaskins Oct 20, 2025 3 min read Novo Nordisk has received FDA approval for Rybelsus for reducing the risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they've had a prior CV event or not (primary and secondary prevention)

MRC Weight Loss Coaches will be there for you every step of the way

Studies have suggested that GLP-1Ra may reduce inflammation through multiple pathways and may be beneficial in reducing kidney disease independent of the presence of diabetes

LAURA: So, last time I injected into the skin on my thigh, but you need to rotate where you inject each time

Semaglutide works by binding to GLP-1 receptors in the brain, which helps to reduce hunger and increase feelings of fullness after eating